We are live on ! Find out more
ENZN

ENZON PHARMACEUTICALS INC
ENZN

Delisted

ENZN was delisted on the 19th of May, 2016.

Back to rankings

67 hedge funds and large institutions have $23.4M invested in ENZON PHARMACEUTICALS INC in 2014 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 23 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% less funds holding

Funds holding: 75 → 67 (-8)

16% less capital invested

Capital invested by funds: $27.9M → $23.4M (-$4.45M)

37% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 19

43% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 23

78% less call options, than puts

Call options by funds: $4K | Put options by funds: $18K

Holders
67
Holders Change
-8
Holders Change %
-10.67%
% of All Funds
1.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
13
Reduced
23
Closed
19
Calls
$4K
Puts
$18K
Net Calls
-$14K
Net Calls Change
+$3K

Top Buyers

Rank Fund Capital Flow
1
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$323K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$288K
3
Millennium Management
Millennium Management
New York
+$194K
4
Bank of America
Bank of America
North Carolina
+$174K
5
PP
Paloma Partners
Connecticut
+$154K

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$1.31M
2
BFA
BlackRock Fund Advisors
California
-$1.1M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$821K
4
Citadel Advisors
Citadel Advisors
Florida
-$579K
5
BIT
BlackRock Institutional Trust
California
-$312K
Name Holding Trade Value Shares
Change 		Change in
Stake
PP
26
Paloma Partners
Connecticut
$168K +$154K +161,481 New
Two Sigma Advisers
27
Two Sigma Advisers
New York
$161K -$5.05K -5,300 -3%
Two Sigma Investments
28
Two Sigma Investments
New York
$140K -$30.9K -32,452 -19%
Acadian Asset Management
29
Acadian Asset Management
Massachusetts
$135K – – –
BIM
30
Bogle Investment Management
Massachusetts
$133K -$95 -100 -0.1%
AG
31
Algert Global
California
$130K – – –
LP
32
LMR Partners
United Kingdom
$117K +$107K +112,501 New
COPPSERS
33
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$111K +$102K +106,947 New
GC
34
Globeflex Capital
California
$105K +$870 +913 +0.9%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$100K -$156K -164,267 -63%
FQ
36
First Quadrant
California
$85K -$95 -100 -0.1%
CS
37
Credit Suisse
Switzerland
$81K +$35.8K +37,603 +93%
Barclays
38
Barclays
United Kingdom
$77K +$5.05K +5,303 +7%
Deutsche Bank
39
Deutsche Bank
Germany
$74K +$51.8K +54,363 +308%
BJ
40
BlackRock Japan
Japan
$66K -$9.77K -10,256 -14%
SFM
41
Soros Fund Management
New York
$52K +$47.8K +50,123 New
D.E. Shaw & Co
42
D.E. Shaw & Co
New York
$41K – – –
VKH
43
Virtu KCG Holdings
New York
$39K +$18.7K +19,635 +113%
State Street
44
State Street
Massachusetts
$38K -$1.31M -1,378,331 -97%
Tudor Investment Corp
45
Tudor Investment Corp
Connecticut
$38K – – –
Nomura Holdings
46
Nomura Holdings
Japan
$32K +$29.1K +30,492 New
TRCT
47
Tower Research Capital (TRC)
New York
$25K +$7.12K +7,468 +44%
Charles Schwab
48
Charles Schwab
California
$23K -$55.3K -58,000 -73%
FA
49
FCG Advisors
New Jersey
$21K – – –
Ameriprise
50
Ameriprise
Minnesota
$18K -$3.95K -4,150 -19%
1
2
3 4

ENZN Hedge Fund Activity: Q2 2014 in Review

67 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in ENZON PHARMACEUTICALS INC (ENZN) for Q2 2014, worth a combined $23.4M — down 16% from $27.9M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of ENZN and 12 opened new positions — a net loss of 7 holders — while 23 trimmed existing stakes and 13 added.

The largest buyer was Schroder Investment Management Group, adding an estimated $323K. The largest seller was State Street, cutting an estimated $1.31M.

  • 67 institutional investors held ENZON PHARMACEUTICALS INC (ENZN) as of Q2 2014, down from 75 in Q1 2014.
  • Funds reported $23.4M of ENZON PHARMACEUTICALS INC stock for Q2 2014, down 16% quarter-over-quarter.
  • 12 funds opened new ENZON PHARMACEUTICALS INC positions in Q2 2014 and 19 closed out, a net change of -7 holders.
  • The largest ENZON PHARMACEUTICALS INC buyer in Q2 2014 was Schroder Investment Management Group, an estimated $323K added.
  • The largest ENZON PHARMACEUTICALS INC seller in Q2 2014 was State Street, an estimated $1.31M sold.

Based on aggregated 13F filings for Q2 2014.